6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04995081
(ClinicalTrials.gov)		July 16, 202116/7/2021Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)A Randomized, Double-Blind, Single Center, Phase 2, Efficacy and Safety Study of Allogeneic HB-adMSCs vs Placebo for the Treatment of Patients With Parkinson's DiseaseParkinson DiseaseBiological: Biological/Vaccine: Allogeneic HB-adMSCs;Other: PlaceboHope Biosciences Stem Cell Research FoundationHope BiosciencesRecruiting45 Years80 YearsAll60Phase 2United States
2NCT04928287
(ClinicalTrials.gov)		June 28, 202126/5/2021Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)A Randomized, Double-Blind, Single Center, Phase 2, Efficacy and Safety Study of Autologous HB-adMSCs vs Placebo for the Treatment of Patients With Parkinson's DiseaseParkinson DiseaseBiological: HB-adMSCs;Other: PlaceboHope Biosciences Stem Cell Research FoundationHope BiosciencesCompleted18 Years75 YearsAll24Phase 2United States